Literature DB >> 21514614

Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.

Yen-Hung Lin1, Hsiu-Hao Lee, Kao-Lang Liu, Jen-Kuang Lee, Shyang-Rong Shih, Shih-Chieh Chueh, Wei-Chou Lin, Lung-Chun Lin, Lian-Yu Lin, Shiu-Dong Chung, Vin-Cent Wu, Chin-Chi Kuo, Yi-Lwun Ho, Ming-Fong Chen, Kwan-Dun Wu.   

Abstract

BACKGROUND: Primary aldosteronism is the most frequent cause of secondary hypertension and is associated with more prominent left ventricular hypertrophy and increased myocardial fibrosis. Unilateral hyperaldosteronism can be cured by adrenalectomy. However, the reversibility of cardiac fibrosis is still unclear.
METHODS: We analyzed 11 patients prospectively with unilateral hyperaldosteronism (including 10 aldosterone-producing adenomas and 1 unilateral nodular hyperplasia) who received adrenalectomy from October 2006 to October 2007, and 17 patients with essential hypertension (EH) were enrolled as the control group. Echocardiography included ultrasonic tissue characterization by cyclic variation of integrated backscatter; it was performed in both groups and 1 year after operation in the unilateral hyperaldosteronism group.
RESULTS: Patients with unilateral hyperaldosteronism had significantly higher diastolic blood pressure, higher plasma aldosterone concentration, lower serum potassium level, and lower plasma renin activity than patients with EH. In echocardiography, patients with unilateral hyperaldosteronism had thicker interventricular septal thickness, left ventricular posterior wall thickness, and higher left ventricular mass index than EH patients. Patients with unilateral hyperaldosteronism had significant lower cyclic variation of integrated backscatter than EH patients (7.1 ± 2.1 vs 8.7 ± 1.5 dB, P = .037). After analyzing the correlation of cyclic variation of integrated backscatter with clinical parameters for all participants, only log-transformed plasma renin activity was correlated significantly with cyclic variation of integrated backscatter. One year after adrenalectomy, interventricular septal thickness, left ventricular posterior wall thickness, and left ventricular mass index decreased significantly. In addition, cyclic variation of integrated backscatter increased significantly after adrenalectomy (7.1 ± 2.1 to 8.5 ± 1.5 dB, P = .02).
CONCLUSION: Adrenalectomy not only reversed left ventricular geometry but also altered myocardial texture in patients with unilateral hyperaldosteronism. This finding implies that increases in collagen content in the myocardium of patients with unilateral hyperaldosteronism might be reversed by adrenalectomy.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21514614     DOI: 10.1016/j.surg.2011.02.006

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

Review 1.  Aldosterone excess and resistant hypertension: investigation and treatment.

Authors:  Michael Stowasser
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

2.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

3.  Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems.

Authors:  Yvette Carter; Madhuchhanda Roy; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2012-08-15       Impact factor: 2.192

4.  Primary aldosteronism in a patient who exhibited heart failure.

Authors:  Caludio Savoriti; Luigi Petramala; Laura Zinnamosca; Luciano Colangelo; Giuseppina Cilenti; Maria C Formicuccia; Cristiano Marinelli; Susanna Sciomer; Camilla Calvieri; Caterina Calvieri; Giorgio De Toma; Claudio Letizia
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-10       Impact factor: 3.738

Review 5.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

Review 6.  Treatment of Primary Aldosteronism and Organ Protection.

Authors:  Cristiana Catena; GianLuca Colussi; Leonardo A Sechi
Journal:  Int J Endocrinol       Date:  2015-05-17       Impact factor: 3.257

7.  The Association between Glomerular Hyperfiltration and Left Ventricular Structure and Function in Patients with Primary Aldosteronism.

Authors:  Min-Tsun Liao; Xue-Ming Wu; Chin-Chen Chang; Che-Wei Liao; Ying-Hsien Chen; Ching-Chu Lu; Yen-Ting Lin; Yi-Yao Chang; Chi-Sheng Hung; Lung-Chun Lin; Chao-Lun Lai; Lian-Yu Lin; Vin-Cent Wu; Yi-Lwun Ho; Kwan-Dun Wu; Yen-Hung Lin
Journal:  Int J Med Sci       Date:  2015-05-03       Impact factor: 3.738

8.  Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism.

Authors:  Chi-Sheng Hung; Yi-Lwun Ho; Yi-Yao Chang; Vin-Cent Wu; Xue-Ming Wu; Jen-Kuang Lee; Shih-Chieh Chueh; Yen-Hung Lin; Yuan-Shian Changh; Shao-Yu Yang; Ya-Hui Hu; Ming-Jai Sui; Ming-Fong Chen; Kwan-Dun Wu
Journal:  ScientificWorldJournal       Date:  2013-12-29

9.  Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.

Authors:  Yen-Hung Lin; Chia-Hung Chou; Xue-Ming Wu; Yi-Yao Chang; Chi-Sheng Hung; Ying-Hsien Chen; Yu-Lin Tzeng; Vin-Cent Wu; Yi-Lwun Ho; Fon-Jou Hsieh; Kwan-Dun Wu
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

10.  Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study.

Authors:  Helga Agusta Sigurjonsdottir; Mikael Gronowitz; Ove Andersson; Robert Eggertsen; Hans Herlitz; Augustinas Sakinis; Bo Wangberg; Gudmundur Johannsson
Journal:  BMC Endocr Disord       Date:  2012-09-08       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.